Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Shareholders' Equity (Unaudited)

v3.21.1
Condensed Statements of Shareholders' Equity (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance (in shares) at Sep. 30, 2019 13,641,805      
Balance at Sep. 30, 2019 $ 136,418 $ 56,976,162 $ 17,820,807 $ 74,933,387
Balance (in shares) at Dec. 31, 2019 13,657,459      
Balance at Dec. 31, 2019 $ 136,575 57,383,020 18,321,965 75,841,560
Balance (in shares) at Sep. 30, 2019 13,641,805      
Balance at Sep. 30, 2019 $ 136,418 56,976,162 17,820,807 74,933,387
Stock-based compensation expense 328,523 328,523
Restricted stock issuance, net of forfeitures (in shares) 9,580      
Restricted stock issuance, net of forfeitures $ 96 (96)
Exercise of stock options, net of shares exchanged for payment (in shares) 3,396      
Exercise of stock options, net of shares exchanged for payment $ 33 2,549 2,582
Tax withholding related to vesting of restricted stock grants (in shares) (453)      
Tax withholding related to vesting of restricted stock grants $ (4) (5,799) (5,803)
Net income 1,249,055 1,249,055
Issuance of common stock under employee stock purchase plan (in shares) 15,107      
Issuance of common stock under employee stock purchase plan $ 151 169,501 169,652
Repurchase of common stock (in shares) (41,796)      
Repurchase of common stock $ (418) (428,236) (428,654)
Balance (in shares) at Mar. 31, 2020 13,627,639      
Balance at Mar. 31, 2020 $ 136,276 57,042,604 19,069,862 76,248,742
Balance (in shares) at Dec. 31, 2019 13,657,459      
Balance at Dec. 31, 2019 $ 136,575 57,383,020 18,321,965 75,841,560
Stock-based compensation expense 87,937 87,937
Restricted stock issuance, net of forfeitures (in shares) 9,580      
Restricted stock issuance, net of forfeitures $ 96 (96)
Exercise of stock options, net of shares exchanged for payment (in shares) 2,396      
Exercise of stock options, net of shares exchanged for payment $ 23 (21) 2
Net income 747,897 747,897
Repurchase of common stock (in shares) (41,796)      
Repurchase of common stock $ (418) (428,236) (428,654)
Balance (in shares) at Mar. 31, 2020 13,627,639      
Balance at Mar. 31, 2020 $ 136,276 57,042,604 19,069,862 76,248,742
Balance (in shares) at Sep. 30, 2020 13,649,962      
Balance at Sep. 30, 2020 $ 136,500 57,502,905 25,113,873 82,753,278
Balance (in shares) at Dec. 31, 2020 13,727,906      
Balance at Dec. 31, 2020 $ 137,279 57,696,847 28,277,312 86,111,438
Balance (in shares) at Sep. 30, 2020 13,649,962      
Balance at Sep. 30, 2020 $ 136,500 57,502,905 25,113,873 82,753,278
Stock-based compensation expense 623,235 623,235
Restricted stock issuance, net of forfeitures (in shares) 36,509      
Restricted stock issuance, net of forfeitures $ 365 (365)
Exercise of stock options, net of shares exchanged for payment (in shares) 33,543      
Exercise of stock options, net of shares exchanged for payment $ 336 (456,460) (456,124)
Tax withholding related to vesting of restricted stock grants (in shares) (2,219)      
Tax withholding related to vesting of restricted stock grants $ (23) (54,185) (54,208)
Net income 6,803,223 6,803,223
Issuance of common stock under employee stock purchase plan (in shares) 15,011      
Issuance of common stock under employee stock purchase plan $ 150 178,931 179,081
Balance (in shares) at Mar. 31, 2021 13,732,806      
Balance at Mar. 31, 2021 $ 137,328 57,794,061 31,917,096 89,848,485
Balance (in shares) at Dec. 31, 2020 13,727,906      
Balance at Dec. 31, 2020 $ 137,279 57,696,847 28,277,312 86,111,438
Stock-based compensation expense 334,178 334,178
Restricted stock issuance, net of forfeitures (in shares) (1,178)      
Restricted stock issuance, net of forfeitures $ (12) 12
Exercise of stock options, net of shares exchanged for payment (in shares) 7,828      
Exercise of stock options, net of shares exchanged for payment $ 79 (193,733) (193,654)
Tax withholding related to vesting of restricted stock grants (in shares) (1,750)      
Tax withholding related to vesting of restricted stock grants $ (18) (43,243) (43,261)
Net income 3,639,784 3,639,784
Balance (in shares) at Mar. 31, 2021 13,732,806      
Balance at Mar. 31, 2021 $ 137,328 $ 57,794,061 $ 31,917,096 $ 89,848,485